Recent studies indicate a possible protective role of the SphK/S1P signaling pathway in T2D, supported by the observation that SphK activation improves the hepatic insulin signaling in obesity and diabetes [91]. This evidence concerns the gene MBTPS1 and obesity due to melanocortin 4 receptor deficiency.